Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$151,307,184
+$12,688,528 QoQ
Shares Held
1,197,619
+20.4% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#104
of 2,284 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026APG Asset Management N.V. holds $2,708,459,664 across 8 Drug Manufacturers - General names. GILD ranks #5 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,210,321 | $1,451,695,438 | |
| 2 | ABBV |
AbbVie Inc.
|
1,613,385 | $405,992,201 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,259,422 | $290,335,727 | |
| 4 | AMGN |
Amgen Inc
|
516,533 | $187,046,929 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
1,197,619 | $151,307,184 | |
| 6 | PFE |
Pfizer Inc
|
4,179,623 | $100,645,321 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,691,386 | $97,457,661 | |
| 8 | BIIB |
Biogen Inc.
|
110,984 | $23,979,203 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $151,307,184 | 1,197,619 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $138,618,656 | 994,609 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $120,590,208 | 982,485 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $117,168,381 | 1,055,571 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $128,513,408 | 1,159,136 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $115,775,886 | 1,033,252 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $113,593,762 | 1,229,769 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $46,911,246 | 559,533 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $128,270,511 | 1,869,560 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $174,849,727 | 2,387,027 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $191,987,867 | 2,369,928 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $195,784,347 | 2,612,548 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $204,546,939 | 2,654,041 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $214,751,002 | 2,588,297 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $248,877,948 | 2,898,986 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $120,759,840 | 1,957,527 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $185,006,230 | 2,993,144 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $178,679,412 | 3,005,541 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $242,012,107 | 3,333,041 | Shares | Defined | 2022-02-11 | |
| 2021-06-30 | $245,054,905 | 3,558,741 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $244,761,500 | 3,787,119 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $232,335,636 | 3,987,910 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $179,000,966 | 2,832,742 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $214,307,906 | 2,785,390 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $84,718,181 | 1,133,202 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||